David Kerr

12PUBLICATIONS
175CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersGene mappingEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
HistoNav: AI-Based H&E Histopathology Predicts Disease-Specific Survival and Guides Adjuvant Chemotherapy Decisions in Stage II/IIIA Colorectal Cancer.

|Oct 15, 2025
A Change of Hallmark: An Update.

Tom Donnem, David Kerr, Leonid L Nikitenko

|Jan 03, 2025
Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis.

Connor E Woolley, Enric Domingo, Juan Fernandez-Tajes

|May 23, 2024
Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.

Edward Briercheck, Doug Pyle, Cary Adams

|Apr 26, 2024
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes.

Zhishan Chen, Xingyi Guo, Ran Tao

|Jan 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer

Pageof 2

Frequent Collaborators

4 joint publications

Claire Palles

3 joint publications

Peter Broderick

3 joint publications

Susan M Farrington

3 joint publications

Philip Law